Google News – Oncology External News
Biotechnology Articles
Google News – Biopharma External News
BioPharma Dive: Young startups miss out on biotech venture funding rebound, MassBio says - Massachusetts Biotechnology Council
Google News – FDA (biotech/pharma) External News
Capricor secures reprieve as FDA extends DMD cell therapy review - Fierce Biotech
Industry News External News
WuXi Biologics posts 4.3% rise in first-half profit, defying biotech headwinds - South China Morning Post
Industry News External News
Overseas licensing has helped fuel China’s biotech profits. Will it last? - South China Morning Post
Google News – Oncology External News
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here’s Who’s Best Positioned. - 24/7 Wall St.
Google News – Biopharma External News
Massachusetts Biopharma Sees Strong Resurgence of Capital Even as Workforce Numbers Lag - Massachusetts Biotechnology Council
Google News – Biopharma External News
Cellares, a cell therapy manufacturing specialist, to lay off 100 employees - BioPharma Dive
Google News – FDA (biotech/pharma) External News
Spruce’s successful FDA talks plant seeds for Q4 filing of ultra-rare disease drug - Fierce Biotech
Google News – FDA (biotech/pharma) External News
Earnings call transcript: Ascelia Pharma narrows Q2 loss as FDA setback weighs on shares - Investing.com
Google News – FDA (biotech/pharma) External News
CDMO Quality Oversight How FDA And Pharma Leaders Are Rethinking Data AI And Culture - Bioprocess Online
Google News – FDA (biotech/pharma) External News
Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine - Pharmaceutical Commerce
Google News – FDA (biotech/pharma) External News
Earnings call transcript: Ascelia Pharma rises 8.2% after FDA setback in Q2 2027 - Investing.com
Google News – FDA (biotech/pharma) External News
Xspray's Dasynoc approval bid foiled again by FDA's manufacturer concerns - Fierce Pharma
Google News – Oncology External News